The Medical University of South Carolina offers a 3-year, ACGME accredited fellowship training program that covers all aspects of gynecologic oncology. The goal is to prepare each fellow to be an innovative leader in field of gynecologic oncology. The fellowship consists of 12 months of protected research and 24 months of clinical experience. The program accepts one fellow each year.
The first year of training the fellow will have 12 months of protected research time. The fellow will complete hypothesis-driven research project and take a graduate level biostatistics course. To complete the research project, the fellow will work directly with a mentor who will guide them through all aspects of the process, including, the data analysis, creating the abstract and the manuscript/thesis with the goal to present their findings at a national scientific meeting and published in a peer-reviewed scientific journal. Division members have research interests in surgical innovation, cancer care delivery and quality improvement.
The second and third year of training are devoted to clinical care. The fellow will participate and become skilled in the surgical and medical management of women with gynecological cancers, including experience performing advanced open and minimally invasive procedures. In addition, they will gain experience in managing chemotherapy treatments and other targeted therapies. The fellow will also gain exposure in field of palliative care, working directly with the palliative care specialists to help each patient navigate their journey.
The Medical University of South Carolina has treated more than 1,100 new gynecologic oncology patients just this year. Our program offers the state’s only female gynecologic oncologist; nationally known radiation oncologists, ovarian cancer specialists and gynecologic pathologists. We specialize in the diagnosis, surgery, treatment and management of cervical, endometrial, ovarian, uterine and vulvar cancers with thoroughness and compassion.
At the forefront of cancer research, MUSC Hollings Cancer Center is one of 73 National Cancer Institute-designated cancer centers in the nation and the only one in South Carolina. This research is the driving force behind delivering medical advances to patients and their families, enabling us to educate health care professionals and the public and to establish outreach services for underserved populations across the state.